Hanwha Solutions reported a Q4 operating loss of 478.2 billion won, more than double market expectations, as weak renewables and chemical segments weighed on results.
#YonhapInfomax #HanwhaSolutions #OperatingLoss #Q4Earnings #RenewableEnergy #ChemicalDivision #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=104059
Celltrion Pharm achieves record Q1 revenue of 112.5 billion won, up 16% year-on-year, driven by strong growth in chemical and biosimilar divisions
#YonhapInfomax #CelltrionPharm #Q1Revenue #ChemicalDivision #BiosimilarDivision #OperatingProfit #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=63416
Celltrion Pharm Reports Record Q1 Revenue of 112.5 Billion Won, Up 16%

Celltrion Pharm achieves record Q1 revenue of 112.5 billion won, up 16% year-on-year, driven by strong growth in chemical and biosimilar divisions

Yonhap Infomax